Health burden and costs of obesity and overweight in Germany.
This study aimed to estimate the health burden and the direct as well as indirect costs of morbidity and mortality attributable to obesity and overweight in Germany for the year 2002. We used the concept of attributable fractions based on German prevalence data and relative risks from US studies as well as routine statistics. We estimated obesity- and overweight-attributable deaths, years of potential life lost (YPLL) and quality-adjusted life years lost (QALY) for various diseases associated with obesity and overweight. Direct costs were estimated for inpatient and outpatient treatment, rehabilitation and non-medical costs. Indirect costs were estimated for sickness absence, early retirement and mortality using the human capital approach. We estimated 36,653 obesity- and overweight-attributable deaths with 428,093 consecutive YPLL and 367,772 QALYs lost. Obesity caused 4,854 million EUR in direct costs corresponding to 2.1% of the overall German health expenditures in 2002 and 5,019 million EUR in indirect costs. Forty-three percent of direct costs resulted from endocrinological diseases like diabetes and obesity itself, followed by cardiovascular diseases (38%), neoplasms (14%) and digestive diseases (6%). Sixty percent of indirect costs resulted from unpaid work, and 67% of overall indirect costs were due to mortality. Obesity and overweight are connected to considerable morbidity and mortality as well as societal costs. Improvement and further development of effective strategies for preventing and dealing with obesity and overweight are necessary.
Konnopka
A
A
Department of Medical Sociology and Health Economics, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. alexander.konnopka@medizin.uni-leipzig.de
Bödemann
M
M
König
H-H
HH
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D017281:Cost of Illness; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000191:economics* / Q000401:mortality*; D015995:Prevalence; D019057:Quality-Adjusted Life Years; D012306:Risk; D012307:Risk Factors; D017678:Sex Distribution; D055815:Young Adult
Tob Control. 2006 Dec;15(6):464-71
17130376
J Occup Environ Med. 2006 Mar;48(3):244-51
16531828
Soz Praventivmed. 2005;50(2):87-94
15900961
Pharmacoeconomics. 2007;25(7):605-18
17610340
Gesundheitswesen. 2005 Mar;67(3):173-82
15789280
Am J Public Health Nations Health. 1967 Mar;57(3):424-40
6066903
Clin Ther. 1998 Jul-Aug;20(4):772-9
9737836
JAMA. 1999 Oct 27;282(16):1523-9
10546691
Econ Hum Biol. 2007 Dec;5(3):392-408
17920000
Lancet. 2002 Nov 2;360(9343):1347-60
12423980
Presse Med. 2007 Jun;36(6 Pt 1):832-40
17329073
Can J Appl Physiol. 2004 Feb;29(1):90-115
15001807
Int J Pediatr Obes. 2008;3 Suppl 1:51-7
18278633
N Engl J Med. 2003 Apr 24;348(17):1625-38
12711737
Gesundheitswesen. 2006 Feb;68(2):110-5
16482491
Value Health. 2008 Jul-Aug;11(4):539-44
18194408
Obes Rev. 2001 Aug;2(3):173-82
12120102
Annu Rev Public Health. 2001;22:355-75
11274526
Ciba Found Symp. 1996;201:194-201; discussion 201-6
9017282
Eur J Health Econ. 2003 Nov;4(4):248-53
15609192
Ugeskr Laeger. 2007 Aug 13;169(33):2634-7
17725912
Eur J Health Econ. 2005 Jun;6(2):124-30
19787848
Obes Rev. 2001 Aug;2(3):189-97
12120104
Med Care. 1997 Nov;35(11):1095-108
9366889
Adv Health Econ Health Serv Res. 1983;4:129-64
10265653